David Kegyes

Cluj-napoca, CJ, Romania

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Integrating Flow Cytometry in the Diagnostic Work of HIV-Associated Hodgkin's Lymphomas.

Integrating Flow Cytometry in the Diagnostic Work of HIV-Associated Hodgkin's Lymphomas.

Journal: Journal of cellular and molecular medicine
Published: February 18, 2026

Integrating venetoclax-based targeted and/or immune therapies for chronic lymphocytic leukemia.

Integrating venetoclax-based targeted and/or immune therapies for chronic lymphocytic leukemia.

Journal: Critical reviews in oncology/hematology
Published: December 14, 2025

The crosstalk between epigenetics and metabolism in the malignant cell.

The crosstalk between epigenetics and metabolism in the malignant cell.

Journal: Discover oncology
Published: December 10, 2025

Proteolysis targeting chimeric-based technology in myeloma and lymphoma.

Proteolysis targeting chimeric-based technology in myeloma and lymphoma.

Journal: Molecular cancer therapeutics
Published: September 22, 2025

Proteolysis Targeting Chimeric-Based Technology in Myeloma and Lymphoma.

Proteolysis Targeting Chimeric-Based Technology in Myeloma and Lymphoma.

Journal: Molecular cancer therapeutics
Published: September 22, 2025

Snapshot Look at Castleman Disease.

Snapshot Look at Castleman Disease.

Journal: Journal of cellular and molecular medicine
Published: August 11, 2025

CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases.

CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases.

Journal: Blood reviews
Published: July 23, 2025

Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies.

Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies.

Journal: Biomarker research
Published: July 16, 2025

Adoptive cellular therapies in non-Hodgkin lymphomas.

Adoptive cellular therapies in non-Hodgkin lymphomas.

Journal: Best practice & research. Clinical haematology
Published: May 13, 2025

Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma.

Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma.

Journal: Biomarker research
Published: May 02, 2025

Adoptive cellular therapies in multiple myeloma.

Adoptive cellular therapies in multiple myeloma.

Journal: Best practice & research. Clinical haematology
Published: April 23, 2025

Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies.

Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies.

Journal: Cell death discovery
Published: March 08, 2025
Showing 1-12 of 32

Last Updated: 09/26/2026